SafeHeal raises €40M for ‘new commonplace of care’ in digestive surgical procedure


Share post:

French startup SafeHeal has closed a €40M financing spherical led by Sofinnova Companions, a European enterprise capital agency and Singapore-based medical system firm, Genesis MedTech. The colovac system goals to ease digestive surgical procedures.


With the funding secured, SafeHeal is to proceed and speed up a operating medical trial named SAFE-2 within the US and Europe which has already been authorized by the FDA. The research goals to guage the security and efficacy of the novel surgical procedure strategy.

Sufferers with colorectal most cancers normally endure an ordinary surgical process that requires two surgical procedures and includes dangers of bodily issues reminiscent of sepsis or dying. The colovac answer was invented by the French surgeon Dr Charam Khosrovani and is designed as a ten day inside versatile bypass sheath inlay that forestalls leakage and contamination of the colorectal anastomotic web site after an open or laparoscopic colorectal surgical procedure. The system might be eliminated endoscopically, and the affected person no longer requires an ostomy pouch.

Because of this SafeHeal predicts that its invention will essentially reshape colorectal surgical procedure and turn into a ‘new commonplace of care’ that may considerably improve the standard of affected person final result and wellbeing.


The French medtech firm SafeHeal was based in Paris in 2015 by MD Begin II, an accelerator program to construct up medical system firms.

VC firm Sofinnova Companions focuses on healthcare and sustainability and backs over 500 firms and market leaders worldwide. Genesis MedTech Group specialises in worth section multi-therapy medical system merchandise in Asia and globally.


Karl-Heinz-Blohm, CEO of SafeHeal, acknowledged: “This funding allows SafeHeal to carry Colovac one step nearer to turning into an ordinary of look after sufferers.”

CEO and Chairman at Genesis MedTech Group, Warren Wang, stated: “This collaboration will speed up the event of this world-class endoluminal bypass sheath, benefiting each sufferers and practitioners.”

Antoine Papiernik, Managing Companion and Chairman of Sofinnova Companions, commented: “This spherical of financing marks the start of a brand new part in SafeHeal’s strategic improvement. The corporate has come a great distance because it was based by the MD Begin II crew, which now leads Sofinnova’s in-house medtech accelerator.”

Supply hyperlink


Please enter your comment!
Please enter your name here


Related articles